BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27479787)

  • 1. Oxidation of methionine - is it limiting the diagnostic properties of 99mTc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist?
    Janota B; Karczmarczyk U; Laszuk E; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2016; 19(2):104-10. PubMed ID: 27479787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake.
    Läppchen T; Tönnesmann R; Eersels J; Meyer PT; Maecke HR; Rylova SN
    PLoS One; 2017; 12(1):e0170435. PubMed ID: 28103285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity.
    Seo D; Faintuch BL; Aparecida de Oliveira E; Faintuch J
    Nucl Med Biol; 2017 Jun; 49():57-64. PubMed ID: 28365524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
    Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
    Wang J; Kim YS; Liu S
    Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A freeze-dried kit formulation for the preparation of Lys(27)(99mTc-EDDA/HYNIC)-Exendin(9-39)/99mTc-EDDA/HYNIC-Tyr3-Octreotide to detect benign and malignant insulinomas.
    Medina-García V; Ocampo-García BE; Ferro-Flores G; Santos-Cuevas CL; Aranda-Lara L; García-Becerra R; Ordaz-Rosado D; Melendez-Alafort L
    Nucl Med Biol; 2015 Dec; 42(12):911-6. PubMed ID: 26364504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys
    Senica K; Tomazic A; Skvarca A; Kolenc Peitl P; Mikolajczak R; Hubalewska-Dydejczyk A; Lezaic L
    Mol Imaging Biol; 2020 Feb; 22(1):165-172. PubMed ID: 31098984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    Bauman A; Valverde IE; Fischer CA; Vomstein S; Mindt TL
    J Nucl Med; 2015 Oct; 56(10):1569-74. PubMed ID: 26251418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.
    Sowa-Staszczak A; Pach D; Mikołajczak R; Mäcke H; Jabrocka-Hybel A; Stefańska A; Tomaszuk M; Janota B; Gilis-Januszewska A; Małecki M; Kamiński G; Kowalska A; Kulig J; Matyja A; Osuch C; Hubalewska-Dydejczyk A
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):524-31. PubMed ID: 23224740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
    Guo H; Miao Y
    J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
    Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
    J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and preclinical characterization of [64Cu]NODAGA-MAL-exendin-4 with a Nε-maleoyl-L-lysyl-glycine linkage.
    Yim CB; Mikkola K; Fagerholm V; Elomaa VV; Ishizu T; Rajander J; Schlesinger J; Roivainen A; Nuutila P; Solin O
    Nucl Med Biol; 2013 Nov; 40(8):1006-12. PubMed ID: 23932646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
    Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
    Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.
    Sowa-Staszczak A; Trofimiuk-Müldner M; Stefańska A; Tomaszuk M; Buziak-Bereza M; Gilis-Januszewska A; Jabrocka-Hybel A; Głowa B; Małecki M; Bednarczuk T; Kamiński G; Kowalska A; Mikołajczak R; Janota B; Hubalewska-Dydejczyk A
    PLoS One; 2016; 11(8):e0160714. PubMed ID: 27526057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution.
    Decristoforo C; Mather SJ
    Nucl Med Biol; 1999 May; 26(4):389-96. PubMed ID: 10382842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.
    Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
    Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
    J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.